Pennant Group (The) (PNTG) Earnings Date & Reports

Key Takeaways

• Third quarter 2026 revenue rose 32.0% year over year to $302.3 million, coming in ahead of consensus estimates near $299 million.
• GAAP diluted earnings per share (EPS) was $0.26, up 52.9% from $0.17 a year earlier, while adjusted diluted EPS of $0.35 was in line with consensus.
• Net income attributable to The Pennant Group grew 58.5% year over year to $9.6 million.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 42.4% to $24.7 million.
• Home Health and Hospice segment revenue rose 38.2% to $239.8 million, while Senior Living revenue increased 12.6% to $62.4 million despite softer occupancy.
• For more context on this ticker's latest developments, explore Major News, Today's Price Move, Price Targets, and Forecast on additional pages.
• To discover AI-driven trading ideas across the market, explore Trending AI Robots.

Earnings Context and Why It Matters

The Pennant Group, a provider of home health, hospice, and senior living services, has been one of the more aggressive consolidators in post-acute care. Its third quarter 2026 report arrived on the heels of a large Southeast acquisition and continued double-digit volume growth across its core segments. For investors, the results matter because they reveal whether recent acquisitions are translating into profitable scale or simply inflating the top line. The quarter also offers a read on reimbursement trends, occupancy in senior living communities, and the rising interest costs tied to deal financing, all of which shape the company's earnings trajectory heading into 2027.

Reported Results

For the third quarter ended September 30, 2026, The Pennant Group reported total revenue of $302.3 million, a 32.0% increase from $229.0 million in the prior-year quarter. The top line came in slightly ahead of consensus estimates of roughly $299 million.

GAAP diluted EPS was $0.26, up from $0.17 a year earlier, while adjusted diluted EPS was $0.35, in line with analyst expectations. Net income attributable to The Pennant Group reached $9.6 million, up 58.5% year over year. Adjusted EBITDA rose 42.4% to $24.7 million, and adjusted EBITDA before noncontrolling interest increased 44.0% to $26.1 million.

Growth was led by the Home Health and Hospice segment, where revenue climbed 38.2% to $239.8 million, supported by both acquisitions and organic admissions growth. Total home health admissions increased 39.4%, and hospice average daily census (ADC), a measure of the average number of patients receiving daily care, rose 34.6%. The Senior Living segment grew revenue 12.6% to $62.4 million, though average occupancy slipped to 78.4% from 80.9% in the prior-year quarter.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking earnings-driven moves like Pennant Group's, it offers a practical way to narrow a broad universe into a focused watchlist.

Market Reaction and Investor Sentiment

The third quarter print delivered a mixed message that investors are likely to weigh carefully. Revenue came in ahead of consensus and adjusted EPS matched expectations, reinforcing the company's growth narrative and acquisition integration progress. At the same time, GAAP EPS landed below some estimates, and the report highlighted a meaningful jump in net interest expense as the company financed its acquisitions, along with a decline in senior living occupancy. These factors point to margin and balance-sheet considerations that could temper enthusiasm even amid strong top-line momentum.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should watch how Pennant converts its acquisition-driven revenue into sustainable margins. Management has indicated results were consistent with its annual guidance, which was raised earlier in 2026 to full-year revenue of $1.17 billion to $1.19 billion and EPS of $1.34 to $1.41. Continued integration of the Southeast operations remains a central theme, with remaining transition work still in progress.

Cost and financing trends also deserve attention. Net interest expense rose sharply year over year, reflecting higher borrowings tied to deal activity, and the company's leverage is worth monitoring alongside its cash-flow generation targets. On the reimbursement side, a planned home health payment increase for 2027 provides a modest tailwind after several years of cuts.

Finally, senior living occupancy will be a key swing factor. The segment's revenue continued to grow, but lower occupancy pressures near-term margins. How quickly occupancy stabilizes or recovers will influence the pace of margin expansion across the broader business.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations